KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Total Liabilities (2016 - 2025)

Historic Total Liabilities for Exact Sciences (EXAS) over the last 17 years, with Q3 2025 value amounting to $3.4 billion.

  • Exact Sciences' Total Liabilities fell 394.2% to $3.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.4 billion, marking a year-over-year decrease of 394.2%. This contributed to the annual value of $3.5 billion for FY2024, which is 600.9% up from last year.
  • As of Q3 2025, Exact Sciences' Total Liabilities stood at $3.4 billion, which was down 394.2% from $3.3 billion recorded in Q2 2025.
  • In the past 5 years, Exact Sciences' Total Liabilities ranged from a high of $3.5 billion in Q3 2024 and a low of $3.1 billion during Q1 2021
  • Its 5-year average for Total Liabilities is $3.3 billion, with a median of $3.3 billion in 2021.
  • Per our database at Business Quant, Exact Sciences' Total Liabilities soared by 6177.69% in 2021 and then tumbled by 439.49% in 2025.
  • Over the past 5 years, Exact Sciences' Total Liabilities (Quarter) stood at $3.3 billion in 2021, then fell by 3.44% to $3.2 billion in 2022, then increased by 4.47% to $3.3 billion in 2023, then increased by 6.01% to $3.5 billion in 2024, then dropped by 3.61% to $3.4 billion in 2025.
  • Its Total Liabilities was $3.4 billion in Q3 2025, compared to $3.3 billion in Q2 2025 and $3.3 billion in Q1 2025.